SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

AT

Ankyra Therapeutics at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Ankyra Therapeutics brings 3 presentations to SITC 2026 in Phoenix. Its program centres on immune-stimulating drugs anchored with alum so they stay in the injected tumor, plus career advice on moving from academia to industry. Its preclinical data show these anchored drugs triggering immune attacks on both the treated tumor and distant ones without body-wide toxicity.

OrganizationSITC 2026 Attendance
AT
Ankyra Therapeutics
Cambridge, MA
Biotech
Develops anchored immunotherapies designed to keep cytokine drugs at the tumor injection site.
Session
Thu Nov 5
12:00pm–1:30pm
Workshop
Thu Nov 5
7:00pm–8:00pm
Early Career Scientist Speed Mentoring
  1. 7:00pm–8:00pmSpeed Mentoring - Group Mentoring
  2. 7:00pm–7:30pmSpeed Mentoring - One-on-One
  3. 7:30pm–8:00pmSpeed Mentoring - One-on-One 2
Session
Fri Nov 6
12:30pm–1:30pm
Rapid Oral - Clinical 1
Clinical
  1. 12:30pm–12:38pmTranscriptional Phenotypes in Basal Keratinocytes Predict Immunotherapy Responsiveness in Cutaneous Squamous Cell CarcinomaStanford University
  2. 12:38pm–12:46pmIntralesional PD-1 Blockade Induces Localized Immune Mobilization and Coordinated Lymphatic Niche Assembly in High-Risk Oral Premalignant LesionsUC San Diego
  3. 12:46pm–12:54pmEVX-01 personalized AI-designed vaccine plus pembrolizumab induce neoantigen-specific T-cell responses and systemic immune modulation in advanced melanomaEvaxion
  4. 1:00pm–1:08pmTargeting IL-1-associated myeloid inflammation to intercept lung precancers: Translational studies and interim results of a Phase 2 trialIcahn School of Medicine at Mount Sinai
  5. 1:08pm–1:16pmSGLT2 inhibitors and incretin-based therapies are associated with increased immune-related toxicity reporting during cancer immunotherapyMayo Clinic
  6. 1:16pm–1:24pmHLA and non-HLA genetic risk are predictive of development of immune checkpoint inhibitor induced diabetesUCSF

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Ankyra Therapeutics

Tell us what you sell and we’ll find the people at Ankyra Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction